These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 11823453)

  • 1. Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome.
    Vatta M; Dumaine R; Varghese G; Richard TA; Shimizu W; Aihara N; Nademanee K; Brugada R; Brugada J; Veerakul G; Li H; Bowles NE; Brugada P; Antzelevitch C; Towbin JA
    Hum Mol Genet; 2002 Feb; 11(3):337-45. PubMed ID: 11823453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mutations in domain I of SCN5A cause Brugada syndrome.
    Vatta M; Dumaine R; Antzelevitch C; Brugada R; Li H; Bowles NE; Nademanee K; Brugada J; Brugada P; Towbin JA
    Mol Genet Metab; 2002 Apr; 75(4):317-24. PubMed ID: 12051963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is sudden unexplained nocturnal death syndrome in Southern China a cardiac sodium channel dysfunction disorder?
    Liu C; Tester DJ; Hou Y; Wang W; Lv G; Ackerman MJ; Makielski JC; Cheng J
    Forensic Sci Int; 2014 Mar; 236():38-45. PubMed ID: 24529773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sodium channel pore mutation causing Brugada syndrome.
    Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
    Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biophysical characterization of the first SCN5A mutation R1512W identified in Chinese sudden unexplained nocturnal death syndrome.
    Zheng J; Zhou F; Su T; Huang L; Wu Y; Yin K; Wu Q; Tang S; Makielski JC; Cheng J
    Medicine (Baltimore); 2016 Jun; 95(23):e3836. PubMed ID: 27281089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome.
    Rook MB; Bezzina Alshinawi C; Groenewegen WA; van Gelder IC; van Ginneken AC; Jongsma HJ; Mannens MM; Wilde AA
    Cardiovasc Res; 1999 Dec; 44(3):507-17. PubMed ID: 10690282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brugada syndrome and fever: genetic and molecular characterization of patients carrying SCN5A mutations.
    Keller DI; Rougier JS; Kucera JP; Benammar N; Fressart V; Guicheney P; Madle A; Fromer M; Schläpfer J; Abriel H
    Cardiovasc Res; 2005 Aug; 67(3):510-9. PubMed ID: 15890323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological characterization of SCN5A mutations causing long QT (E1784K) and Brugada (R1512W and R1432G) syndromes.
    Deschênes I; Baroudi G; Berthet M; Barde I; Chalvidan T; Denjoy I; Guicheney P; Chahine M
    Cardiovasc Res; 2000 Apr; 46(1):55-65. PubMed ID: 10727653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct functional defect of three novel Brugada syndrome related cardiac sodium channel mutations.
    Hsueh CH; Chen WP; Lin JL; Tsai CT; Liu YB; Juang JM; Tsao HM; Su MJ; Lai LP
    J Biomed Sci; 2009 Feb; 16(1):23. PubMed ID: 19272188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel pore mutation in SCN5A manifests as a spectrum of phenotypes ranging from atrial flutter, conduction disease, and Brugada syndrome to sudden cardiac death.
    Rossenbacker T; Carroll SJ; Liu H; Kuipéri C; de Ravel TJ; Devriendt K; Carmeliet P; Kass RS; Heidbüchel H
    Heart Rhythm; 2004 Nov; 1(5):610-5. PubMed ID: 15851228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced Na(+) channel intermediate inactivation in Brugada syndrome.
    Wang DW; Makita N; Kitabatake A; Balser JR; George AL
    Circ Res; 2000 Oct; 87(8):E37-43. PubMed ID: 11029409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mechanism for Brugada syndrome: defective surface localization of an SCN5A mutant (R1432G).
    Baroudi G; Pouliot V; Denjoy I; Guicheney P; Shrier A; Chahine M
    Circ Res; 2001 Jun; 88(12):E78-83. PubMed ID: 11420310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The implications of genetic mutations in the sodium channel gene (SCN5A).
    Moric E; Herbert E; Trusz-Gluza M; Filipecki A; Mazurek U; Wilczok T
    Europace; 2003 Oct; 5(4):325-34. PubMed ID: 14753626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of function associated with novel mutations of the SCN5A gene in patients with Brugada syndrome.
    Baroudi G; Napolitano C; Priori SG; Del Bufalo A; Chahine M
    Can J Cardiol; 2004 Mar; 20(4):425-30. PubMed ID: 15057319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single Na(+) channel mutation causing both long-QT and Brugada syndromes.
    Bezzina C; Veldkamp MW; van Den Berg MP; Postma AV; Rook MB; Viersma JW; van Langen IM; Tan-Sindhunata G; Bink-Boelkens MT; van Der Hout AH; Mannens MM; Wilde AA
    Circ Res; 1999 Dec 3-17; 85(12):1206-13. PubMed ID: 10590249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and electrophysiological characteristics of Brugada syndrome caused by a missense mutation in the S5-pore site of SCN5A.
    Itoh H; Shimizu M; Mabuchi H; Imoto K
    J Cardiovasc Electrophysiol; 2005 Apr; 16(4):378-83. PubMed ID: 15828879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical Roles of Xirp Proteins in Cardiac Conduction and Their Rare Variants Identified in Sudden Unexplained Nocturnal Death Syndrome and Brugada Syndrome in Chinese Han Population.
    Huang L; Wu KH; Zhang L; Wang Q; Tang S; Wu Q; Jiang PH; Lin JJ; Guo J; Wang L; Loh SH; Cheng J
    J Am Heart Assoc; 2018 Jan; 7(1):. PubMed ID: 29306897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long QT and Brugada syndrome gene mutations in New Zealand.
    Chung SK; MacCormick JM; McCulley CH; Crawford J; Eddy CA; Mitchell EA; Shelling AN; French JK; Skinner JR; Rees MI
    Heart Rhythm; 2007 Oct; 4(10):1306-14. PubMed ID: 17905336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel LQT3 mutation implicates the human cardiac sodium channel domain IVS6 in inactivation kinetics.
    Groenewegen WA; Bezzina CR; van Tintelen JP; Hoorntje TM; Mannens MM; Wilde AA; Jongsma HJ; Rook MB
    Cardiovasc Res; 2003 Mar; 57(4):1072-8. PubMed ID: 12650885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional Characterization of Two Novel Mutations in
    Balla C; Conte E; Selvatici R; Marsano RM; Gerbino A; Farnè M; Blunck R; Vitali F; Armaroli A; Brieda A; Liantonio A; De Luca A; Ferlini A; Rapezzi C; Bertini M; Gualandi F; Imbrici P
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.